SE421423B - Analogiforfarande for framstellning av 6-metyl-8beta-(substituerad metyl) ergoliner - Google Patents

Analogiforfarande for framstellning av 6-metyl-8beta-(substituerad metyl) ergoliner

Info

Publication number
SE421423B
SE421423B SE7513641A SE7513641A SE421423B SE 421423 B SE421423 B SE 421423B SE 7513641 A SE7513641 A SE 7513641A SE 7513641 A SE7513641 A SE 7513641A SE 421423 B SE421423 B SE 421423B
Authority
SE
Sweden
Prior art keywords
methyl
8beta
ergolines
preparation
analogy procedure
Prior art date
Application number
SE7513641A
Other languages
English (en)
Swedish (sv)
Other versions
SE7513641L (sv
Inventor
E C Kornfeld
N J Bach
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7513641L publication Critical patent/SE7513641L/xx
Publication of SE421423B publication Critical patent/SE421423B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7513641A 1974-12-06 1975-12-03 Analogiforfarande for framstellning av 6-metyl-8beta-(substituerad metyl) ergoliner SE421423B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/530,318 US3985752A (en) 1974-12-06 1974-12-06 6-Methyl-8-(substituted) methylergolines

Publications (2)

Publication Number Publication Date
SE7513641L SE7513641L (sv) 1976-06-08
SE421423B true SE421423B (sv) 1981-12-21

Family

ID=24113213

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7513641A SE421423B (sv) 1974-12-06 1975-12-03 Analogiforfarande for framstellning av 6-metyl-8beta-(substituerad metyl) ergoliner
SE7513640A SE421422B (sv) 1974-12-06 1975-12-03 Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7513640A SE421422B (sv) 1974-12-06 1975-12-03 Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin

Country Status (29)

Country Link
US (1) US3985752A (lv)
JP (2) JPS5946235B2 (lv)
AR (2) AR208104A1 (lv)
AT (2) AT348141B (lv)
AU (1) AU498226B2 (lv)
BE (1) BE836308A (lv)
BG (3) BG33435A3 (lv)
CA (2) CA1062252A (lv)
CH (2) CH619465A5 (lv)
CS (2) CS200483B2 (lv)
DD (2) DD123749A5 (lv)
DE (1) DE2554000A1 (lv)
DK (2) DK547675A (lv)
ES (3) ES443276A1 (lv)
FR (1) FR2293203A1 (lv)
GB (1) GB1526835A (lv)
GR (2) GR60025B (lv)
HU (3) HU173724B (lv)
IE (1) IE42372B1 (lv)
IL (1) IL48573A (lv)
MX (1) MX3113E (lv)
NL (1) NL7514058A (lv)
PH (1) PH12630A (lv)
PL (3) PL102195B1 (lv)
RO (2) RO65456A (lv)
SE (2) SE421423B (lv)
SU (3) SU694075A3 (lv)
YU (2) YU304775A (lv)
ZA (1) ZA757624B (lv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
AU526764B2 (en) * 1978-09-08 1983-01-27 Farmitalia Carlo Erba S.P.A. Ergoline derivatives
HU180467B (en) * 1979-07-12 1983-03-28 Gyogyszerkutato Intezet Process for producing new ergol-8-ene- and ergoline-sceleted compounds
US4683313A (en) * 1985-06-24 1987-07-28 Eli Lilly And Company 2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles
JPH0541005Y2 (lv) * 1987-07-14 1993-10-18
JPH02174820A (ja) * 1988-12-27 1990-07-06 Sekisui Chem Co Ltd トイレット
WO2000054776A1 (en) * 1999-03-17 2000-09-21 Eugen Eigenmann Use of prolactin inhibitors for the treatment of fertility problems in animal species
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695752C3 (de) * 1966-07-29 1974-06-06 Societa Farmaceutici Italia, Mailand (Italien) 1 ,ö-Dimethyl-ebeta-N-carbobenzoxyaminomethyl-2,3-dihydro-1 Oalpha-ergolin und ein Verfahren zu seiner Herstellung
BE712054A (lv) * 1967-03-16 1968-07-15

Also Published As

Publication number Publication date
ES457709A1 (es) 1978-03-01
IE42372B1 (en) 1980-07-30
FR2293203A1 (fr) 1976-07-02
CH617197A5 (lv) 1980-05-14
DE2554000A1 (de) 1976-06-16
PL106884B1 (pl) 1980-01-31
DK142321C (lv) 1981-03-09
YU304775A (en) 1982-02-28
MX3113E (es) 1980-04-18
SE421422B (sv) 1981-12-21
IL48573A (en) 1979-03-12
AR208104A1 (es) 1976-11-30
SE7513640L (sv) 1976-06-08
SU724085A3 (ru) 1980-03-25
ES443276A1 (es) 1977-08-16
PL102195B1 (pl) 1979-03-31
HU175228B (hu) 1980-06-28
AU8718275A (en) 1977-06-09
BE836308A (fr) 1976-06-08
DK142321B (da) 1980-10-13
DK547575A (lv) 1976-06-07
CA1062253A (en) 1979-09-11
HU173724B (hu) 1979-07-28
DK547675A (da) 1976-06-07
ATA927975A (de) 1978-04-15
SU685155A3 (ru) 1979-09-05
GR60026B (en) 1978-03-31
SE7513641L (sv) 1976-06-08
GR60025B (en) 1978-03-31
AT347050B (de) 1978-12-11
ES443275A1 (es) 1977-09-16
HU173847B (hu) 1979-09-28
CS200483B2 (en) 1980-09-15
RO64281A (fr) 1979-07-15
BG33288A3 (en) 1983-01-14
AT348141B (de) 1979-01-25
IL48573A0 (en) 1976-01-30
ATA927875A (de) 1978-06-15
SU694075A3 (ru) 1979-10-25
CS199609B2 (en) 1980-07-31
RO65456A (ro) 1980-01-15
JPS5182300A (lv) 1976-07-19
JPS59210085A (ja) 1984-11-28
PH12630A (en) 1979-07-05
JPS6017795B2 (ja) 1985-05-07
DD123749A5 (lv) 1977-01-12
IE42372L (en) 1976-06-06
YU304875A (en) 1982-02-28
FR2293203B1 (lv) 1978-07-28
CH619465A5 (lv) 1980-09-30
DD123748A5 (lv) 1977-01-12
AR207664A1 (es) 1976-10-22
JPS5946235B2 (ja) 1984-11-10
AU498226B2 (en) 1979-02-22
BG33287A3 (en) 1983-01-14
NL7514058A (nl) 1976-06-09
BG33435A3 (en) 1983-02-15
US3985752A (en) 1976-10-12
ZA757624B (en) 1977-07-27
PL102198B1 (pl) 1979-03-31
GB1526835A (en) 1978-10-04
USB530318I5 (lv) 1976-01-13
CA1062252A (en) 1979-09-11

Similar Documents

Publication Publication Date Title
SE420095B (sv) Analogiforfarande for framstellning av 8-tiometyl-ergoliner
DK148905C (da) Analogifremgangsmaade til fremstilling af lh-rh-analoge nonapeptidderivater
SE424320B (sv) Analogiforfarande for framstellning av derivat av 3-sulfonamido-4-amino-pyridiner
NO142175C (no) Analogifremgangsmaate for fremstilling av sulfonater av s-adenosil-l-methionin
TR19139A (tr) Laktatdehidrojenazenin izoenzimlerinin hepbirden tesbitine mahsus usul
NO146096C (no) Analogifremgangsmaate ved fremstilling av thienothiazinderivater
SE419548B (sv) Analogiforfarande for framstellning av 1-metyl-dihydrolysegoyl-nitroargininol-dekanoat
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
DK145542C (da) Analogifremgangsmaade til fremstilling af ergolinforbindelser
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE421423B (sv) Analogiforfarande for framstellning av 6-metyl-8beta-(substituerad metyl) ergoliner
DK343275A (da) Fremgangsmade til fremstilling af cephalosporinderivater
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE430895B (sv) Forfarande for kontinuerlig framstellning av cellulosaglykolat
SE426827B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner
DK151025C (da) Fremgangsmaade til fremstilling af alkoxylerede derivater af beta-lactam-antibiotica
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
DK296175A (da) Fremgangsmade til fremstilling af cephalosporinderivater
SE7513879L (sv) Forfarande for syntes av karbamider
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
DK435375A (da) Fremgangsmade til fremstilling af cephalosporinderivater
SE7513490L (sv) Forfarande for framstellning av finfordelad volframkarbid

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7513641-6

Effective date: 19880923

Format of ref document f/p: F